Css LLC Viking Therapeutics, Inc. Transaction History

Css LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	BUY	$3.0 - $4.88 $30,000 - $48,800	10,000 Added 51.93%	29,258 $88,000
Q1 2021 May 17, 2021	BUY	$5.74 - $9.67 $12,960 - $21,834	2,258 Added 13.28%	19,258 $122,000
Q3 2020 Nov 16, 2020	SELL	$5.73 - $8.11 $5,730 - $8,109	-1,000 Reduced 5.56%	17,000 $99,000
Q2 2020 Aug 14, 2020	SELL	$4.35 - $8.08 $87,000 - $161,600	-20,000 Reduced 52.63%	18,000 $130,000
Q1 2020 May 15, 2020	BUY	$3.45 - $7.95 $112,125 - $258,375	32,500 Added 590.91%	38,000 $178,000
Q4 2019 Feb 14, 2020	BUY	$6.38 - $8.73 $35,090 - $48,015	5,500 New	5,500 $44,000

473

66.2M

5.72M

3.39M

Ticker VKTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,688,496
Market Cap $4.03B
Description
Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. The company's lead drug candidate is VK2809, an orally available tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta (TRß), which is in Phase IIb clinical trial...

Get notified when there are updates to the investment portfolio of Css LLC, based on Form 13F filings with the SEC.

Stay updated on Css LLC with notifications on news.